✦ LIBER ✦

Combination therapy of low dose alfa-interferon and medroxyprogesterone acetate in metastatic renal cell cancer. A randomized multicenter trial

✍ Scribed by F. Porzsolt; D. Messerer; R. Hautmann; A. Gottwald; H. Sparwasser; K. Stockamp; W. Aulitzky; J.G. Moormam; K. Schumacher; H. Rasche; U. Papendick; W. Schreml

Book ID: 116006948
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 176 KB
Volume: 28
Category: Article
ISSN: 0022-4731
DOI: 10.1016/0022-4731(87)91620-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon alfa and vinblastine versus m

Interferon alfa and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinoma

✍ M. Kriegmair; R. Oberneder; A. Hofstetter 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 497 KB

A randomized comparative trial of combin

A randomized comparative trial of combined versus alternating therapy with cytostatic drugs and high-dose medroxyprogesteron acetate in advanced breast cancer

✍ Jacques A. Wils; Hein Bron; Leo Van Lange; Martin Pannebakker; Anton Romme; Herm 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

Medroxyprogesterone, interferon alfa-2a,

Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis : Results of a randomized controlled trial

✍ Sylvie Negrier; David Perol; Alain Ravaud; Christine Chevreau; Jacques-Olivier B 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

## Abstract ## BACKGROUND. Few randomized trials have compared the survival benefit of interferon‐alfa over controls in metastatic renal cell carcinoma, and none has been performed using interleukin‐2. The Programme Etude Rein Cytokines (PERCY) Quattro trial was designed to evaluate both cytokines

Randomized Phase III Trial of Temsirolim

Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial

✍ Rini, B. I.; Bellmunt, J.; Clancy, J.; Wang, K.; Niethammer, A. G.; Hariharan, S 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 266 KB

Treatment of advanced renal cell cancer

Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate

✍ F. Porzsolt; D. Messerer; R. Hautmann; A. Gottwald; H. Sparwasser; K. Stockamp; 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 602 KB

A phase-II study of combination of pegyl

A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer

✍ Kaisa Leea Sunela; Sanna Koskinen; Pirkko-Liisa Kellokumpu-Lehtinen 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 348 KB